New stent trial aims to improve outcomes for tough heart blockages
NCT ID NCT07491107
First seen Apr 03, 2026 · Last updated May 15, 2026 · Updated 7 times
Summary
This study will track 2000 people with complex coronary artery disease who receive the Inspiron EVO drug-eluting stent during a procedure to open blocked heart arteries. The goal is to see how well the stent works and how safe it is in real-world use. Participants must be 18 or older and have complex blockages requiring a stent.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
Porto Alegre, Rio Grande do Sul, 90610000, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.